Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865393/0/en/IMUNON-s-IND-Application-Cleared-to-Begin-Human-Testing-of-IMNN-101.html
https://www.globenewswire.com/news-release/2024/03/28/2853938/0/en/IMUNON-Reports-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/25/2851608/0/en/IMUNON-Receives-1-3-Million-from-Sale-of-its-New-Jersey-Net-Operating-Losses.html
https://www.globenewswire.com/news-release/2024/03/21/2850655/0/en/IMUNON-to-Hold-2023-Financial-Results-and-Business-Update-Conference-Call-on-Thursday-March-28-2024.html
https://www.globenewswire.com//news-release/2024/03/13/2845364/0/en/IMUNON-Files-IND-Application-to-Begin-Human-Testing-of-IMNN-101.html
https://www.globenewswire.com//news-release/2024/03/12/2845063/0/en/IMUNON-Announces-Leadership-Change.html
https://www.globenewswire.com//news-release/2024/02/29/2837973/0/en/Independent-Lab-Confirms-Immunogenicity-and-Protection-with-IMUNON-s-IMNN-101-in-a-Live-Virus-Challenge-Against-SARS-CoV-2-Variant-XBB-1-5.html
https://www.globenewswire.com//news-release/2024/02/27/2836041/0/en/Memorial-Sloan-Kettering-Cancer-Center-Now-Enrolling-Patients-in-Phase-1-2-Clinical-Trial-of-IMUNON-s-IMNN-001-in-Combination-with-Bevacizumab-in-Advanced-Ovarian-Cancer.html
https://www.globenewswire.com//news-release/2024/02/22/2833646/0/en/IMNN-101-Preclinical-Data-in-SARS-CoV-2-Published-in-Peer-Reviewed-Journal-Vaccine.html
https://www.globenewswire.com//news-release/2023/12/11/2793865/0/en/IMUNON-Appoints-Dr-Sebastien-Hazard-as-Chief-Medical-Officer-and-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html